Drug discovery team
Our Drug Discovery Institute couples the biological expertise of international collaborators with innovative in-house drug discovery expertise. Our Institute houses dedicated biology, chemistry, pharmacology and screening teams to evaluate promising new targets. We then establish assays to screen compound libraries for hits against these targets and improve hits into potent and selective lead compounds. This provides the basis for the development of the next generation of medicines to treat neurodegeneration.
|Head of Biology:||Jamie Bilsland|
Alexandra van Ingelgom
Daniel Bull (PhD Student)
|Pharmacology and Screening|
|Head of Pharmacology and Screening:||Magda Bictash|
|Head of Chemistry:||Paul Fish|